Stress in healthy uncooperative dental patient.
Conditions
Interventions
Intervention 1: Group 1 received 0.5 mg/kg oral Midazolam syrup (Amsed, 2.5 mg/ml, Dales Pharmaceutical, England) 30 -45 minutes before treatment. Intervention 2: Group 2 was given 0.3 mg/kg buccal Mi
Treatment - Drugs
Group 1 received 0.5 mg/kg oral Midazolam syrup (Amsed, 2.5 mg/ml, Dales Pharmaceutical, England) 30 -45 minutes before treatment
Group 2 was given 0.3 mg/kg buccal Midazolam (Epistatus, 10mg/ml, Special Product Ltd, England), 15-30 minutes prior dental procedure. The other regimen was used at the second appointment.
Sponsors
Dental school- Shahed University
Eligibility
Sex/Gender
All
Age
2 Years to 6 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: those who needed bilateral and identical restorative and pulp treatment requiring 2 or more dental visits and were unable to tolerate the dental procedure with behavior management techniques. Those with contraindication to Midazolam, upper respiratory tract infection, tonsilar hypertrophy were excluded.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stress. Timepoint: At discharge. Method of measurement: VAS.;Parents acceptebility. Timepoint: At discharge. Method of measurement: Questionnaire.;Physiologic outcomes. Timepoint: Before treatment,each 10 minutes, at discharge. Method of measurement: Pulse oximeter. | — |
Secondary
| Measure | Time frame |
|---|---|
| Parental acceptability. Timepoint: Discharge time. Method of measurement: Questionnair. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSara Tavassoli
Shahed University
Outcome results
None listed